<DOC>
	<DOCNO>NCT00681668</DOCNO>
	<brief_summary>The purpose study evaluate efficacy tolerability quetiapine female patient postpartum depressive disorder psychotic symptom</brief_summary>
	<brief_title>Quetiapine Postpartum Depression</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depression , Postpartum</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Provision sign informed consent . Female patient severe postpartum depressive disorder psychotic symptom minimum HAMD cut score 20 point Woman preexist psychotic disorder Patients alcohol substance abuse dependence Patients pose imminent risk suicide danger self others</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Postpartum Depression</keyword>
	<keyword>Quetiapine</keyword>
	<keyword>Psychotic Symptoms</keyword>
</DOC>